Description

TB-500 is a synthetic research peptide associated with thymosin beta-4-related biology. Thymosin beta-4 is an actin-binding protein involved in cellular movement and cytoskeletal organisation, and TB-500 is commonly investigated in research involving cell migration, angiogenic signalling and tissue remodelling.

MMRR TB-500 is supplied in a 10 mg vial. Every MMRR batch is independently third-party tested under the MMRR testing program, including identity, chromatographic purity and peptide-content evaluation, with additional quality attributes assessed where applicable.

Manufactured in Atlantic Canada. For research purposes only. No dosing or medical-use guidance is provided.

Additional information

Size	10 mg

Reviews

There are no reviews yet.

Be the first to review “TB-500”

Independent third-party testing

Every MMRR product batch is independently tested by a third-party laboratory before release. Core analytical testing is designed to confirm identity, chromatographic purity and peptide content, with additional impurity, moisture, residual-solvent, elemental and microbiological testing used where applicable to the product and batch.

Testing is product- and batch-specific. MMRR does not treat a purity percentage as a substitute for identity, content or microbiological testing.

Read about MMRR testing ↗